Phase 3 Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to give written consent to take part
- People aged between 18 and 65 years old
- People who have been diagnosed with Type 1 Diabetes according to recognised 2024 medical guidelines
- People whose blood tests show 2 or more specific markers (called autoantibodies) that are linked to Type 1 Diabetes — there is a special rule that applies if insulin has been used for more than 14 days, where at least 2 additional markers must be present (confirm with trial site)
- People who were diagnosed with Type 1 Diabetes no more than 100 days before joining the trial
- People whose blood test shows a certain level of a substance called C-peptide, which indicates the body is still producing some insulin (confirm with trial site for the specific value required)
Who may not be able to join:
- People who are pregnant, breastfeeding, or people who could become pregnant and are not using contraception
- People whose blood sugar is already well managed using only tablets (oral diabetes medication)
- People who are currently taking part in another clinical trial related to diabetes or the immune system
- People whose liver enzyme levels (measured by a blood test) are significantly higher than normal
- People with a history of cancer, poorly controlled autoimmune conditions, or a current active infection
- People with alcohol or drug dependency, certain psychiatric conditions, or other health circumstances that the trial team considers unsuitable for participation
- People who have taken immune-suppressing medications within the 12 weeks before joining
- People who have taken part in any other drug trial within the 12 weeks before joining
- People with a known history of serious drug allergies, hypersensitivity reactions, or drug addiction
- People whose overall health situation is considered by the research team to be unsuitable for the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 13814084876
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Baseline-adjusted geometric mean area under the serum C-peptide curve (C-peptide AUC) during a 2-hour mixed-meal tolerance test (MMTT) 24 weeks post-intervention.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.